US 10737995
Nuclear receptor modulators and their use for the treatment and prevention of cancer
granted A61KA61K31/12A61K31/275
Quick answer
US patent 10737995 (Nuclear receptor modulators and their use for the treatment and prevention of cancer) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Aug 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/12, A61K31/275, A61K45/06, A61P